Emirates Health Services (EHS) exhibited robotic surgeries during a live broadcast on February 12, 2022, at the start of its Innovative Projects Exhibition at Expo 2020 Dubai.
The live broadcast demonstrating robotic surgery is seen as one of the most noteworthy achievements to be brought to the health-care system.
The exhibition forms part of EHS’ agenda of activities for UAE Innovation Month, which includes a bundle of innovative and interactive events.
“The launch of the Innovative Projects Exhibition, which includes pioneering initiatives and events, reflects Emirates Health Services’ commitment to leading the health services sector and offering top-quality innovative health services that meet the highest international standards and embrace advanced smart innovations,” said HE. Dr. Abdulaziz Abdullah Al Zarooni, Acting Executive Director of the Financial Sector and Support Services at EHS.
His Excellency added that the innovative projects offered by EHS and its affiliated entities are part of its preparations for the next stage of transformations in the healthcare sector. They aim to automate services and develop strategies for using artificial intelligence (AI) in order to achieve customer satisfaction and boost the UAE’s competitiveness regionally and globally.
Also on the agenda for the remainder of UAE Innovation Month is a series of panel discussions and youth circles organised by the EHS Youth Council, in addition to virtual and in-person discussion seminars, presented by a group of EHS experts in an effort to increase awareness of various aspects of the healthcare sector.
Emirates Health Services will also organise virtual training programmes in Arabic during the second half of UAE Innovation Month, the first of which is titled ‘Emotional and Social Intelligence: Applicability in Healthcare’, and the second ‘Value-Based Healthcare: Return on Investment’. Last but not least, EHS will also organise a webinar on big data and information in healthcare and another on the human genome, precision medicine, and pharmacogenetics.
